Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

67.78 +0.40 (+0.59%)

Official Closing Price Updated: 4:15 PM EST, Dec 30, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	422,652
Open	67.23
Bid (Size)	67.20 (300)
Ask (Size)	68.00 (200)
Prev. Close	67.38
Today's Range	66.80 - 68.88
52wk Range	13.22 - 94.90
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Case for Small-Cap Diversification: Why Investors are Looking Beyond Mega-Cap Tech

December 23, 2025

As 2025 draws to a close, the "Magnificent Seven" era of market dominance is facing its most significant challenge yet. While the first half of the year was characterized by a relentless surge in...

Via MarketMinute

Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts

December 23, 2025

BAGSVAERD, Denmark — In a landmark decision that has sent shockwaves through the global pharmaceutical industry, Novo Nordisk (NYSE:NVO) has secured U.S. Food and Drug Administration (FDA) approval for...

Via MarketMinute

Performance

YTD	+140.4%	+140.4%
1 Month	+96.1%	+96.1%
3 Month	+167.9%	+167.9%
6 Month	+226.8%	+226.8%
1 Year	+154.5%	+154.5%

More News

Why Did Structure Therapeutics Stock Surge Pre-Market Today? ↗

December 08, 2025

Via Stocktwits

The Great Rotation: Small-Caps Seize the Spotlight as Mega-Cap Fatigue Sets In

December 22, 2025

Via MarketMinute

The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains

December 18, 2025

Via MarketMinute

The Great Rotation: Small-Caps Break Out as Russell 2000 Hits Record Highs in Late 2025

December 18, 2025

Via MarketMinute

Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

December 17, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs

December 11, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants

December 09, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Why Structure Therapeutics Stock Doubled and Then Some on Monday ↗

December 08, 2025

Via The Motley Fool

Global Markets Brace for Fed Decision Amidst Divergent Policies and Geopolitical Crosscurrents

December 09, 2025

Via MarketMinute

Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants

December 08, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

What's going on in today's session ↗

December 08, 2025

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

December 08, 2025

Via Chartmill

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

December 08, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

December 07, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 07, 2025

Via Benzinga

Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

November 06, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

This Under-the-Radar Healthcare Stock Could Soar in 2026 ↗

September 12, 2025

Via The Motley Fool

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

September 02, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform

August 18, 2025

Via AB Newswire

Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound ↗

August 07, 2025

Via Stocktwits

Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations

August 07, 2025

Via MarketMinute

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors ↗

August 07, 2025

Via Benzinga

Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge. ↗

August 07, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?

Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.

What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?

Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?

The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market

What is the current price of Structure Therapeutics Inc. - American Depositary Shares?

The current price of Structure Therapeutics Inc. - American Depositary Shares is 67.78

When was Structure Therapeutics Inc. - American Depositary Shares last traded?

The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 12/30/25 04:15 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.